Showing results (21-30 of 75) with videos related to
Sort By:
Pageof 8
Frontiers in Immunology|November 5, 2021
Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human MonocytesPierre-Louis Krauss, Moritz Pfeiffenberger, Alexandra Damerau, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2025
Fracture Fusion on Fast-Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta-AnalysisDaniel Müller, Jens Klotsche, Magdalena B Kosik, et al.International Journal of Nanomedicine|February 1, 2017
Plant-derived pectin nanocoatings to prevent inflammatory cellular response of osteoblasts following Porphyromonas gingivalis infectionAnna Meresta, Justyna Folkert, Timo Gaber, et al.International Journal of Molecular Sciences|December 30, 2020
A Human Osteochondral Tissue Model Mimicking Cytokine-Induced Key Features of Arthritis In VitroAlexandra Damerau, Moritz Pfeiffenberger, Marie-Christin Weber, et al.Frontiers in Immunology|June 8, 2023
Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)Lisa Christ, Andrea D Gloor, Florian Kollert, et al.International Journal of Nanomedicine|November 24, 2016
Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humansCindy Strehl, Lionel Maurizi, Timo Gaber, et al.Blood|May 19, 2005
Rapid immunosuppressive effects of glucocorticoids mediated through Lck and FynMark Löwenberg, Jurriaan Tuynman, Joyce Bilderbeek, et al.Toxicology Letters|January 18, 2016
Effects of PVA-coated nanoparticles on human T helper cell activityCindy Strehl, Saskia Schellmann, Lionel Maurizi, et al.Immunologic Research|January 2, 2016
Disentangling the effects of tocilizumab on neutrophil survival and functionTimo Gaber, Martin Hahne, Cindy Strehl, et al.Immunologic Research|October 8, 2011
Inflammatory synovial fluid microenvironment drives primary human chondrocytes to actively take part in inflammatory joint diseasesEric Röhner, Georg Matziolis, Carsten Perka, et al.Pageof 8